BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Domenech M, Sempere J, de Miguel S, Yuste J. Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract. Front Immunol 2018;9:2700. [PMID: 30515172 DOI: 10.3389/fimmu.2018.02700] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Richi P, Yuste J, Navío T, González-Hombrado L, Salido M, Thuissard-Vasallo I, Jiménez-Díaz A, Llorente J, Cebrián L, Lojo L, Steiner M, Cobo T, Martín MD, García-Castro M, Castro P, Muñoz-Fernández S. Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases. Vaccines (Basel) 2021;9:203. [PMID: 33671007 DOI: 10.3390/vaccines9030203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Kumar SB, Arnipalli SR, Ziouzenkova O. Antibiotics in Food Chain: The Consequences for Antibiotic Resistance. Antibiotics (Basel) 2020;9:E688. [PMID: 33066005 DOI: 10.3390/antibiotics9100688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
3 Pirofski LA, Casadevall A. Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage. Antimicrob Agents Chemother 2020;64:e01800-19. [PMID: 31740558 DOI: 10.1128/AAC.01800-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Huang W, Zhang Q, Li W, Chen Y, Shu C, Li Q, Zhou J, Ye C, Bai H, Sun W, Yang X, Ma Y. Anti-outer Membrane Vesicle Antibodies Increase Antibiotic Sensitivity of Pan-Drug-Resistant Acinetobacter baumannii. Front Microbiol 2019;10:1379. [PMID: 31275290 DOI: 10.3389/fmicb.2019.01379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
5 Proctor LL, Ward WL, Roggy CS, Koontz AG, Clark KM, Quinn AP, Schroeder M, Brooks AE, Small JM, Towne FD, Brooks BD. Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections. Antibiotics (Basel) 2021;10:1530. [PMID: 34943742 DOI: 10.3390/antibiotics10121530] [Reference Citation Analysis]
6 Mayor A, Chesnay A, Desoubeaux G, Ternant D, Heuzé-Vourc'h N, Sécher T. Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives. Vaccines (Basel) 2021;9:151. [PMID: 33668613 DOI: 10.3390/vaccines9020151] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Corsini B, Aguinagalde L, Ruiz S, Domenech M, Yuste J. Vaccination with LytA, LytC, or Pce of Streptococcus pneumoniae Protects against Sepsis by Inducing IgGs That Activate the Complement System. Vaccines (Basel) 2021;9:186. [PMID: 33672306 DOI: 10.3390/vaccines9020186] [Reference Citation Analysis]
8 Sempere J, de Miguel S, González-Camacho F, Yuste J, Domenech M. Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain. Front Microbiol 2020;11:309. [PMID: 32174903 DOI: 10.3389/fmicb.2020.00309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
9 Naskar A, Kim KS. Black phosphorus nanomaterials as multi-potent and emerging platforms against bacterial infections. Microb Pathog 2019;137:103800. [PMID: 31610220 DOI: 10.1016/j.micpath.2019.103800] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
10 Bianchini S, Argentiero A, Camilloni B, Silvestri E, Alunno A, Esposito S. Vaccination against Paediatric Respiratory Pathogens. Vaccines (Basel) 2019;7:E168. [PMID: 31683882 DOI: 10.3390/vaccines7040168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Duan L, Zhang J, Chen Z, Gou Q, Xiong Q, Yuan Y, Jing H, Zhu J, Ni L, Zheng Y, Liu Z, Zhang X, Zeng H, Zou Q, Zhao Z. Antibiotic Combined with Epitope-Specific Monoclonal Antibody Cocktail Protects Mice Against Bacteremia and Acute Pneumonia from Methicillin-Resistant Staphylococcus aureus Infection. J Inflamm Res 2021;14:4267-82. [PMID: 34511967 DOI: 10.2147/JIR.S325286] [Reference Citation Analysis]